Table 1 Sociodemographic and clinical characteristics of patients with carbamazepine intoxication. Continuous variables are presented as average ± SEM, ordinal variables are presented as number and percentage
All patients | Neurological Symptoms | |||
|---|---|---|---|---|
(n = 80) | Non-Severe (n = 70) | Severe (n = 10) | p-value* | |
Age (Years) | 43.4 ± 2.0 | 45.2 ± 2.1 | 30.0 ± 3.5 | 0.00 |
Gender (% female) | 38 (47.5) | 32 (45.7) | 4 (40) | 0.39 |
Ethnicity: | 0.03 | |||
Arab | 25 (31.3) | 24 (34.3) | 1 (10) | |
Jews | 54 (67.5) | 46 (66.7) | 8 (80) | |
Others | 1 (1.3) | 0 | 1 (10) | |
Smokers | 6 (7.5) | 6 (8.9) | 0 (0) | 0.196 |
Chronic Carbamazepine users | 67 (83.8) | 59 (84.3) | 8 (80) | 0.32 |
Indications for carbamazepine: | ||||
Epileptic seizures | 50 (62.5) | 47 (67.1) | 4 (40) | 0.09 |
Psychiatric disorder | 27 (33.7) | 20 (28.5) | 7 (70) | 0.013 |
Neuropathic pain | 4 (5) | 4 (5.7) | 0 (0) | 0.29 |
Othersa | 5 (6.2) | 5 (7.1) | 0 (0) | |